Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Healthcare Realty Trust Announces Strategic Joint Venture With KKR
-
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
-
Meritage Homes Announces Offering of Convertible Senior Notes
-
Pivotal Helix eVTOL Wins 2024 MUSE Transportation Design of the Year Award
-
Oculis to Present at Bank of America Global Healthcare Conference
-
Freshpet, Inc. Reports First Quarter 2024 Financial Results
-
Lilium Announces Firm Order of 20 Lilium Jets from U.S. Operator UrbanLink
-
Hut 8 Operations Update for April 2024
-
K92 Mining Announces Latest Drilling Results Extending Multiple High-Grade Zones and New Dilatant Zone Discovered
-
Teleflex Announces Quarterly Dividend
-
ICPO Foundation awards ICPO Academy stipends to the Department of Nuclear Medicine at Osaka University Hospital
-
Teleflex Announces Quarterly Dividend
-
Net Asset Value(s)
-
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
-
Transactions in connection with share buyback programme
-
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting
-
Verkkokauppa.com Oyj: Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act; Samuli Seppälä’s holding in Verkkokauppa.com
-
Sydbank share buyback programme: transactions in week 18
-
H World Group Limited Schedules First Quarter of 2024 Earnings Release on May 17, 2024
-
Verkkokauppa.com Oyj - Managers' Transactions – Seppälä
-
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
-
MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
-
Pulsar Helium Announces Spring Road Restrictions End at Topaz Project
-
Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division
-
Integra LifeSciences Reports First Quarter 2024 Financial Results
-
AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD)
-
USI Insurance Services Acquires Hignojos Insurance Agency
-
ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma
-
AI and Big Data Take the Centre Stage in Central Asia at Beetech 2024 Hosted by Beeline Kazakhstan and QazCode
-
Ferrari N.V.: Periodic Report on the Buyback Program
-
Prepayments, Realkredit Danmark A/S
-
Crypto Rating Agency ARIA Creating a New Investment Risk Metric with Platform Launch
-
The News Forum - Energy Creates Launches Nation-Wide Scholarship Contest Offering $500,000 in Prizes to Youth 15 – 25
-
Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia
-
Orion Corporation: Managers’ transactions – Veli-Matti Mattila
-
Orion Corporation: Managers’ transactions – Maziar Mike Doustdar
-
Orion Corporation: Managers’ transactions – Kari Jussi Aho
-
Orion Corporation: Managers’ transactions – Karen Lykke Sørensen
-
Orion Corporation: Managers’ transactions – Hilpi Rautelin
-
Orion Corporation: Managers’ transactions – Henrik Stenqvist
-
Orion Corporation: Managers’ transactions – Eija Ronkainen
-
Orion Corporation: Managers’ transactions – Ari Lehtoranta
-
Godkendelse af afdelingsfusion og vedtægter i Investeringsforeningen SEBinvest
-
SHARE BUYBACK TRANSACTIONS
-
Virbac : Declaration of the number of shares and voting rights
-
Curium Announces First Commercial Doses in Germany of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer
-
Correction: Share buy-back programme - week 18
-
Mattermost Playbooks Elevate Real-Time Cybersecurity Automation to Accelerate Compliance with New SEC & CISA Regulations
-
Mattermost Playbooks Elevate Real-Time Cybersecurity Automation to Accelerate Compliance with New SEC & CISA Regulations
-
Master the complexities of Pillar Two with our New Online Course!


